Collectively, these data strongly indicated that targeting WDR5 not only suppressed tumour proliferation and enhance the efficacy of cisplatin for BCa cells in vivo but also reduced the toxicity and side effects for normal tissues. Here, WDR5 is linked to neoplasm.